Patheon, a business unit of DPx Holdings B.V., delivers a combination of
unrivaled quality, reliability and compliance, with a reputation for
scientific and technical excellence to customers in the pharmaceutical
and biopharma sector. A leading global provider with more than 8,000
employees worldwide, Patheon has a comprehensive set of solutions to
help customers of all sizes satisfy complex development and
manufacturing needs at any stage of the pharmaceutical development
Ronald Pate, Lyophilization Development Scientist at Patheon will be the keynote speaker at this year's Lyophilisation USA Conference April 29-30 in Iselin, NJ.
Pate's presentation "Cycle Development Basic Concepts and Optimising the Process” talks about reviewing cycle development to enhance optimisation, validation and increased stability of the protein, and how to enable shorter cycle times for cost efficient processing of lyophilised formulations while ensuring consistency within a batch and between batches.